Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense Suppression
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Nonsense suppression therapy is an approach to treat genetic diseases caused by nonsense mutations. This therapeutic strategy pharmacologically suppresses translation termination at Premature Termination Codons (PTCs) in order to restore expression of functional protein. However, the process of Nonsense-Mediated mRNA Decay (NMD), which reduces the abundance of mRNAs containing PTCs, frequently limits this approach. Here, we used a mouse model of the lysosomal storage disease mucopolysaccharidosis I-Hurler (MPS I-H) that carries a PTC in the Idua locus to test whether NMD attenuation can enhance PTC suppression in vivo. Idua encodes alpha-L-iduronidase, an enzyme required for degradation of the glycosaminoglycans (GAGs) heparan sulfate and dermatan sulfate. We found that the NMD attenuator NMDI-1 increased the abundance of the PTC-containing Idua transcript. Furthermore, co-administration of NMDI-1 with the PTC suppression drug gentamicin enhanced alpha-L-iduronidase activity compared to gentamicin alone, leading to a greater reduction of GAG storage in mouse tissues, including the brain. These results demonstrate that NMD attenuation significantly enhances suppression therapy in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543 · cited 1×
“Previous studies have shown that the activities of several lysosomal enzymes are upregulated in tissues derived from mouse models of several lysosomal storage diseases as a consequence of excess GAG storage [38].”
Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells
Vattem, K. M., & Wek, R. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400541101 · Cited by 1,696 · cited 1×
“These include transcripts with upstream ORFs such as Aft4, or with long or intron-containing 39 untranslated regions such as Gas5 [34–36].”
Yamashita, A., Ohnishi, T., Kashima, I., Taya, Y., & Ohno, S. (2001) · Genes & Development · doi:10.1101/gad.913001 · Cited by 420 · cited 1×
“SMG1 kinase inhibitors, including caffeine, wortmannin, and LYS294002, prevent UPF1 phosphorylation [18,23].”
Weischenfeldt, J., Damgaard, I., Bryder, D., Theilgaard-Mönch, K., Thoren, L. A., Nielsen, F. C., Jacobsen, S. E. W., Nerlov, C., & Porse, B. T. (2008) · Genes & Development · doi:10.1101/gad.468808 · Cited by 288 · cited 1×
“Deletion of UPF1, UPF2, or SMG1 result in embryonic lethality in mice, suggesting a critical role for NMD and/or NMD factors during mammalian development [43– 45].”
Extending Natures Leads: The Anticancer Agent Ellipticine
Garbett, N., & Graves, D. (2004) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011043482070 · Cited by 137 · cited 1×
“In contrast, ellipticine, an antineoplastic compound [33] that is structurally related to NMDI-1 (Figure S1B), did not inhibit NMD.”
Wang, D., Shukla, C., Liu, X., Schoeb, T. R., Clarke, L. A., Bedwell, D. M., & Keeling, K. M. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.08.002 · Cited by 62
Self-citation
Cited by
The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy
Lindeboom, R. G. H., Vermeulen, M., Lehner, B., & Supek, F. (2019) · Nature Genetics · doi:10.1038/s41588-019-0517-5 · Cited by 327
Alternative ORFs and small ORFs: shedding light on the dark proteome
Orr, M. W., Mao, Y., Storz, G., & Qian, S.-B. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz734 · Cited by 319
Therapeutics Based on Stop Codon Readthrough
Keeling, K. M., Xue, X., Gunn, G., & Bedwell, D. M. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153527 · Cited by 306
“In contrast to those negative results, numerous other in vitro studies found that PTC124 suppresses nonsense mutations and restores deficient protein function associated with numerous disorders, including MPS VI (9), MPS I-H (100), Usher syndrome (47, 48), infantile neuronal ceroid lipofuscinosis (119), propionic acid…”
InfluentialSelf-citationA human microprotein that interacts with the mRNA decapping complex
D'Lima, N. G., Ma, J., Winkler, L., Chu, Q., Loh, K. H., Corpuz, E. O., Budnik, B. A., Lykke-Andersen, J., Saghatelian, A., & Slavoff, S. A. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2249 · Cited by 304
Ge, Z., Quek, B. L., Beemon, K. L., & Hogg, J. R. (2016) · eLife · doi:10.7554/elife.11155 · Cited by 157
Metadata
- Authors
- Keeling, K. M., Wang, D., Dai, Y., Murugesan, S., Chenna, B., Clark, J., Belakhov, V., Kandasamy, J., Velu, S. E., Baasov, T., & Bedwell, D. M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-10
- Volume
- 8
- Issue
- 4
- Pages
- e60478
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2014746879
- Cited by
- 119
- References
- 7
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense Suppression. https://app.cochat.ai/papers/10.1371/journal.pone.0060478
- The paper
- Keeling, K. M., Wang, D., Dai, Y., Murugesan, S., Chenna, B., Clark, J., Belakhov, V., Kandasamy, J., Velu, S. E., Baasov, T., & Bedwell, D. M. (2013). Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense Suppression. PLoS ONE. https://doi.org/10.1371/journal.pone.0060478
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.